Daysee Kit
Product Images NDC 68180-846

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Daysee (NDC 68180-846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 01

A bar chart showing the percentage of bleeding and/or spotting and bleeding alone over four cycles (Days 1-91, 92-182, 183-273, 274-364) with sample sizes ranging from 758 in Cycle 1 to 446 in Cycle 4. Each cycle has paired bars indicating percentages for ≥7 days and ≥20 days, with the percentage values labeled inside the bars.*

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 02

A horizontal forest plot titled 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use' listing multiple studies with effect estimates and confidence intervals depicted as points with horizontal lines. The plot displays odds ratios (OR), relative risks (RR), and hazard ratios (HR) with corresponding numeric values and 95% confidence intervals on the right. The horizontal axis ranges from -1.50 to 2.00 labeled as 'Effect Estimate.' The chart visually compares statistical measures across various women's health studies.*

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 03

Chemical structure of Levonorgestrel, showing its molecular formula C21H28O2 and molecular weight 312.4. The structure illustrates the arrangement of carbon, hydrogen, and oxygen atoms in the molecule with stereochemical details.*

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 04

Chemical structure of the active ingredient Ethinyl Estradiol, showing the molecular formula C20H24O2 and a molecular weight (MW) of 296.4.*

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 05

An illustration depicting various birth control methods arranged vertically by effectiveness, with fewer pregnancies at the top and more pregnancies at the bottom. Methods listed include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal rings, condoms, diaphragms, abstinence during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 06

Instructional diagram for Daysee contraceptive kit showing a 4-week calendar layout with days of the week labeled Sunday through Saturday. Circles represent pill placement for each day, with arrows indicating the sequence of daily pill intake. Storage instructions noting controlled room temperature (25°C/77°F, with permitted excursions between 15° to 30°C) are included. Branding includes the Daysee name and Lupin logo.*

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 07

A drug administration schedule for Daysee, a kit containing levonorgestrel and ethinyl estradiol tablets (0.15 mg/0.03 mg) and ethinyl estradiol tablets (0.01 mg). The image displays a 4-week pill-taking chart labeled Week 5 through Week 8 with days of the week (Sunday to Saturday). It also includes a note for monthly self breast exams and storage instructions at 25°C (77°F), allowing excursions from 15° to 30°C (59° to 86°F).*

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 08

A dosage schedule diagram for Daysee (levonorgestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg and ethinyl estradiol tablets USP 0.01 mg). The diagram shows weeks 9 through 13, with each week having rows of seven circles representing days Sunday through Saturday. Arrows indicate the sequence to follow daily. To the right is a note to perform a monthly self-breast exam, and storage instructions specify 25°C (77°F), with permitted excursions between 15° to 30°C (59° to 86°F).*

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 09

Daysee kit containing levonorgestrel and ethinyl estradiol tablets USP (0.15 mg/0.03 mg) and ethinyl estradiol tablets USP (0.01 mg). The packaging includes multiple weekly blister panels for oral administration with days of the week labeled. Distributed by Lupin Pharmaceuticals, Inc. and manufactured by Lupin Limited, India. Storage instructions and monthly self-breast exam reminders are also visible.*

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 10

Daysee kit containing levonorgestrel and ethinyl estradiol tablets USP (0.15 mg/0.03 mg) and ethinyl estradiol tablets USP (0.01 mg) by Lupin Pharmaceuticals. The label states it is a prescription-only extended-cycle wallet of 91 tablets, with warnings about use and storage. Includes barcodes, lot number, and expiration date area.*

FDA Label Image

Cf858b7a C9b0 4ff0 B2d7 B59ef268a525 11

Daysee kit packaging label showing active ingredients levonorgestrel and ethinyl estradiol tablets USP in specified dosages. The label indicates 2 extended-cycle wallets of a total 91 tablets, including 84 light blue film-coated tablets and 7 mustard film-coated tablets. Distributed by Lupin Pharmaceuticals, Inc., and manufactured by Lupin Limited, India. The label includes NDC 68180-846-13 and standard prescription drug warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.